Skip to content

Prospective clinical study on sexuality in neurodivergent individuals - SENSE: Sexuality and Neurodiversity Symptoms & Empirical Research

Prospective clinical study on sexuality in neurodivergent individuals - SENSE: Sexuality and Neurodiversity Symptoms & Empirical Research - SENSE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039496
Enrollment
400
Registered
2026-03-17
Start date
2026-09-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F90.0 F84.5

Interventions

Group 1: Individuals with Autism Spectrum Disorder (ASD) (App-based questionnaires and questions on sexuality, sexual orientation, and gender identity over a total period of 6 months) Group 2: Individ

Sponsors

LVR Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants aged 18–65 years with either a diagnosis of autism spectrum disorder or attention deficit disorder will be included. In addition, age- and education-matched control participants will be recruited. Only individuals with sufficient German language proficiency to independently complete the German-language online questionnaires will be eligible for inclusion.

Exclusion criteria

Exclusion criteria: Severe intellectual disability, serious and acute physical or mental illness, such as an acute psychosis, brain injury, Alzheimer’s disease, or a severe bacterial infection requiring immediate treatment, and insufficient German language skills.

Design outcomes

Primary

MeasureTime frame
Examination of differences in sexuality and gender identity between individuals with ASD or ADHD, based on the clinical data collected. Differences due to the recruitment method: Identification of variations in findings on sexuality and gender identity between participants recruited online versus in person. Conducting multiple data collections at different measurement time points (longitudinal assessments). Data collection takes place on a maximum of 66 days within a total period of 183 days. During the initial phase (Day 1 to Day 6), questions are administered daily. From Day 7 onward, assessments are conducted every three days following a standardized schedule, with the ten questionnaires repeating in a fixed 30-day cycle. Each scale is administered a total of six times. The maximum total time required for participation is up to 670 minutes (˜ 11.5 hours) over a period of six months. Day 1: Baseline assessment and single measurements: approx. 20–25 minutes Single measurements: Age, level of education/years of education, biological sex, gender identity, diagnosis yes/no (ASD / ADHD); if yes: time of diagnosis, who made the diagnosis (clinic / specialist physician / self-report), AQ test (Autism Quotient), ASRS (Adult ADHD Self-Report Scale), comorbidities (somatic and psychiatric disorders), current medication use, sexually transmitted infections (yes/no; if yes, which), age at first masturbation, age at first sexual intercourse, number of previous partnerships, duration of the current / last partnership Baseline assessment: Kinsey Scale, relationship status, partnerships/romantic relationships/sexual partners by gender, presence of sexual interest, presence of sexual contacts / time of last sexual contact, contraceptive methods, risk behavior (substance misuse: excessive consumption of alcohol/cannabis; sexual activities without contraception; frequently changing sexual partners), Sexual Behavior Questionnaire (SBQ), Utrecht Gender Dysphoria Scale, Short Quest

Secondary

MeasureTime frame
Therapeutic Implications: Development of approaches based on the individual needs of the examined groups in order to enable targeted therapeutic support.

Countries

Germany

Contacts

Public ContactFranziska Kümpers

LVR Klinikum Düsseldorf

Franziska.Kuempers@lvr.de02119223300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026